Fibrinogen concentrate improves clot strength in patients with haematological malignancies requiring platelet transfusion-Reference-Cited by-同舟云学术

Fibrinogen concentrate improves clot strength in patients with haematological malignancies requiring platelet transfusion

Published:2016-05-30 Issue:4 Volume:26 Page:291-296
ISSN:0958-7578
Container-title:Transfusion Medicine
language:en
Short-container-title:Transfusion Med

Author:

Munk-Andersen H.¹,Schenk B.²,Larsen O.H.³⁴,Fries D.²,Fenger-Eriksen C.¹⁴

Affiliation:

1. Department of Anaesthesiology; Aarhus University Hospital; Aarhus Denmark

2. Department for General and Surgical Intensive Care Medicine; Medical University Innsbruck; Innsbruck Austria

3. Department of Haematology; Aarhus University Hospital; Aarhus Denmark

4. Centre for Haemophilia and Thrombosis, Department of Clinical Biochemistry; Aarhus University Hospital; Aarhus Denmark

Funder

LFB Biomedicaments

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/tme.12323/fullpdf

Reference20 articles.

1. The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage;Charbit;Journal of Thrombosis and Haemostasis,2007

2. Association between fibrinogen level and severity of postpartum haemorrhage: secondary analysis of a prospective trial;Cortet;British Journal of Anaesthesia,2012

3. Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation;Estcourt;The Cochrane Database of Systematic Reviews,2012

4. Fibrinogen replacement therapy: a critical review of the literature;Franchini;Blood Transfusion,2012

5. Beyond the platelet count: immature platelet fraction and thromboelastometry correlate with bleeding in patients with immune thrombocytopenia;Greene;British Journal of Haematology,2014

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fibrinogen contribution to clot strength in patients with sepsis and hematologic malignancies and thrombocytopenia—a prospective, single-center, analytical, cross-sectional study;Research and Practice in Thrombosis and Haemostasis;2024-02

2. Achieving haemostasis in thrombocytopenia in remote settings: an in vitro comparison of frozen and lyophilized products;BLOOD TRANSFUS-ITALY;2023

3. Cryoprecipitate as an alternative to platelet transfusion in thrombocytopenia;eJHaem;2021-12-08

4. Fibrinolysis in patients with chemotherapy‐induced thrombocytopenia and the effect of platelet transfusion;Journal of Thrombosis and Haemostasis;2019-05-24

5. Metabolomics study on promoting blood circulation and ameliorating blood stasis: Investigating the mechanism of Angelica sinensis and its processed products;Biomedical Chromatography;2019-01-09